Intralytix

About:

Intralytix is a biotechnology company focused on the discovery, production and marketing.

Website: http://www.intralytix.com/

Twitter/X: intralytix

Top Investors: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Lesaffre

Description:

Intralytix is a biotechnology company focused on the discovery, production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. Bacteriophages (bacteria-eater: from the Greek phago meaning "to eat" or "to develop at the expense of") are the most abundant microorganisms on earth. They are the natural enemies of bacteria. Lytic bacteriophages can very effectively kill their targeted specific bacteria without affecting anything else, ensuring an unprecedented level of safety for an antimicrobial.

Total Funding Amount:

$17.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

1998-01-01

Contact Email:

info(AT)intralytix.com

Founders:

John Woloszyn

Number of Employees:

11-50

Last Funding Date:

2020-05-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai